🔎 Trials Near Me

Domov › Sladkorna bolezen tipa 2 › Texas › Dallas

Klinične študije za Sladkorna bolezen tipa 2 v Dallas, TX

19 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Vključevanje udeležencevFaza 3
  • North Texas Endocrine Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Vključevanje udeležencevFaza 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Vključevanje udeležencevFaza 3
  • University of Texas Southwestern Medical Center, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Vključevanje udeležencev
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Vse starosti · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research, Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 2
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Velocity Clinical Research, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • University of Texas Southwestern Medical Center, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Vključevanje udeležencevFaza 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research - Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Vključevanje udeležencevFaza 3
  • Thyroid Endocrinology & Diabetes PA, Dallas
  • Baylor Jack and Jane Hamilton, Dallas
Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Vključevanje udeležencevFaza 3
  • Research Institute of Dallas, Dallas
Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

Vključevanje udeležencevFaza 1/2
  • UT Southwestern Medical Center, Dallas
Starost 18–100 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Vključevanje udeležencevFaza 2
  • Zenos Clinical Research, Dallas
Starost 18–70 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Velocity Clinical Research Dallas, Dallas
Starost 18 in več · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Vključevanje udeležencev
  • UT Southwestern Medical Center, Dallas
Starost 18–60 · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT05168605

Študije za Sladkorna bolezen tipa 2 v drugih mestih

Druge študije v Dallas

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.